Top compounds associated with response to LGALS7


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.016 0.7
mRNA myricetin CTRPv2 pan-cancer AAC -0.016 0.7
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA lapatinib gCSI pan-cancer AAC -0.022 0.7
mRNA ML258 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA MST-312 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA tandutinib CTRPv2 pan-cancer AAC 0.015 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
Download CSV